Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
申请人:Eckhardt Matthias
公开号:US20050209166A1
公开(公告)日:2005-09-22
Glucopyranosyl-substituted benzene derivatives of general formula I
where the groups R
1
to R
6
as well as R
7a
, R
7b
, R
7c
are defined herein and the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
[DE] GLUCOPYRANOSYL-SUBSTITUIERTE BENZOL-DERIVATE, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, DEREN VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG<br/>[EN] GLUCOPYRANOSYL-SUBSTITUTED BENZOL DERIVATIVES, DRUGS CONTAINING SAID COMPOUNDS, THE USE THEREOF AND METHOD FOR THE PRODUCTION THEREOF<br/>[FR] DERIVES DU BENZOL SUBSTITUES PAR UN GLUCOPYRANOSYLE,, MEDICAMENTS RENFERMANT CES COMPOSES, LEUR UTILISATION ET LEUR PROCEDE DE PRODUCTION
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2005092877A1
公开(公告)日:2005-10-06
Glucopyranosyl-substituierte Benzol-Derivate der allgemeinen Formel (I), wobei die Reste R1 bis R6 sowie R7a, R7b, R7c gemäss Anspruch 1 definiert sind, einschliesslich deren Tautomere, deren Stereoisomere, deren Gemische und deren Salze. Die erfindungsgemässe Verbindungen sind geeignet zur Behandlung von Stoffwechselerkrankungen.
[EN] PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE POUR LE TRAITEMENT DU CANCER
申请人:GENENTECH INC
公开号:WO2017205538A1
公开(公告)日:2017-11-30
The present invention relates to a compound formula (I): and to salts thereof, wherein R1, R2X, and Y have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders such as cancer, inflammatory disorders and autoimmune diseases.
The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
METHOD FOR PRODUCING 1-(4-HYDROXYPHENYL)-4-(4-TRIFLUOROMETHOXYPHENOXY)PIPERIDINE OR SALT THEREOF
申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:US20180065931A1
公开(公告)日:2018-03-08
The present invention provides a method for producing 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or a salt thereof, the method including the step of heating hydroquinone and 4-(4-trifluoromethoxyphenoxy)piperidine. This method can produce 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or a salt thereof in an industrially advantageous manner.